Development of a spatially defined 3D in vitro coculture construct modeling pancreatic cancer-associated cachexia
Source abstract
Abstract
Abstract Pancreatic cancer-associated cachexia is marked by adipose tissue wasting, thermogenic remodeling, and a state of hypermetabolism, yet robust preclinical models to study these phenomena are lacking. In this study, we present a spatially defined three-dimensional (3D) core–shell microcuboid coculture platform designed to investigate the interaction between adipocytes and pancreatic cancers. This innovative system consists of differentiated white adipocytes at the core, surrounded by pancreatic ductal adenocarcinoma (PDAC) cells embedded in 3D-printed microcuboids, arranged concentrically within a collagen coculture matrix construct. Within this framework, we observed significant enhancement of adipocyte lipolysis and browning, as evidenced by BODIPY dye-tracked lipid migration, sustained glycerol release, and progressive expression of extracellular UCP1 or the mitochondrial brown fat uncoupling protein 1, particularly pronounced in cocultures involving aggressive pancreatic cancer cell lines. The integrity of the core–shell architecture persisted for up to 21 d but progressively disintegrated under the influence of the cancer cells marked by cancer cell invasion into the adipocyte regions. Gene profiling revealed a downregulation of adipogenic markers, such as Pparg, Plin1 , and Lipe , alongside an increase in Ucp1 transcripts, suggesting a metabolic shift from lipid storage to utilization and thermogenic activation. In contrast to existing 3D engineered systems, our platform offers enhanced long-term viability, controlled compartmentalization, mechanical tunability, and high spatiotemporal resolution. It effectively recapitulates the dynamic interplay between cancer and adipose cells, along with the catabolic characteristics of PDAC-associated cachexia, serving as a scalable in vitro tool for mechanistic investigations, and for testing potential anti-cachexia interventions, filling the gap between simplistic in vitro assays and complex animal models.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Adipose Tissue and Metabolism · Cancer Research and Treatments · Adipokines, Inflammation, and Metabolic Diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
University of Nebraska Medical Center
University of Nebraska
Funding
Fred & Pamela Buffett Cancer Center Pilot Project
References (52)
Show source-provided references
1. Prognostic effect of weight loss prior tochemotherapy in cancer patients10.1016/S0149-2918(05)80001-3 ↗
2. Symptom prevalence in patients with incurable cancer: a systematic review10.1016/j.jpainsymman.2006.10.015 ↗
3. Cancer-associated cachexia—understanding the tumour macroenvironment and microenvironment to improve management10.1038/s41571-023-00734-5 ↗
4. Cancer cachexia: understanding the molecular basis10.1038/nrc3829 ↗
5. GRP75 triggers white adipose tissue browning to promote cancer-associated cachexia10.1038/s41392-024-01950-w ↗
6. Trends in the global incidence of pancreatic cancer and a brief review of its histologic and molecular subtypes10.1007/s12029-025-01183-2 ↗
7. Cachexia, and not obesity, prior to pancreatic cancer diagnosis worsens survival and is negated by chemotherapy10.21037/jgo.2017.11.10 ↗
8. Incidence and frequency of cancer cachexia during chemotherapy for advanced pancreatic ductal adenocarcinoma10.1007/s00520-020-05346-8 ↗
9. Adipose tissue wasting as a determinant of pancreatic cancer-related cachexia10.3390/cancers14194754 ↗
10. Pancreatic cancer cachexia: three dimensions of a complex syndrome10.1038/s41416-021-01301-4 ↗
11. A Switch from white to brown fat increases energy expenditure in cancer-associated cachexia10.1016/j.cmet.2014.06.011 ↗
12. Uncovering tumor-promoting roles of activin a in pancreatic ductal adenocarcinoma10.1002/advs.202207010 ↗
13. Visceral adipose tissue remodeling in pancreatic ductal adenocarcinoma cachexia: the role of activin A signaling10.1038/s41598-022-05660-7 ↗
14. The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy10.1002/jcsm.12461 ↗
15. Role of growth differentiation factor 15 in cancer cachexia10.3892/ol.2023.14049 ↗
16. Interaction between adipose tissue and cancer cells: role for cancer progression10.1007/s10555-020-09934-2 ↗
17. The role of dysfunctional adipose tissue in pancreatic cancer: a molecular perspective10.3390/cancers12071849 ↗
18. Exosomal miR-155 from gastric cancer induces cancer-associated cachexia by suppressing adipogenesis and promoting brown adipose differentiation via C/EPBβ10.20892/j.issn.2095-3941.2021.0220 ↗
19. Exosomal miRNAs in tumor microenvironment10.1186/s13046-020-01570-6 ↗
20. Extracellular vesicles in tumor-adipose tissue crosstalk: key drivers and therapeutic targets in cancer cachexia10.20517/evcna.2024.36 ↗
21. Integrin β1 in pancreatic cancer: expressions, functions, and clinical implications10.3390/cancers14143377 ↗
22. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma10.1016/j.ccr.2012.01.007 ↗
23. Cancer‐associated adipocytes exhibit distinct phenotypes and facilitate tumor progression in pancreatic cancer10.3892/or.2019.7365 ↗
24. In vitro models for cancer-associated cachexia: the complex modelling of a multiorgan syndrome10.3390/app14135419 ↗
25. Optimization of a mouse model of pancreatic cancer to simulate the human phenotypes of metastasis and cachexia10.1186/s12885-024-12104-0 ↗
26. Modeling human cancer-induced cachexia10.1016/j.celrep.2019.07.016 ↗
27. Cancer-associated adipocytes promote pancreatic cancer progression through SAA1 expression10.1111/cas.14527 ↗
28. Modeling human cancer cachexia in colon 26 tumor-bearing adult mice10.1007/s13539-014-0141-2 ↗
29. 3D bioprinted white adipose model forin vitro study of cancer-associated cachexia induced adipose tissue remodeling10.1088/1758-5090/ac6c4b ↗
30. One-step fabrication of highly customizable porous core–shell microspheres for the construction of a 3D physiologically relevant perivascular-endosteal multi-microenvironment model of breast cancer bone metastasis10.1002/adfm.202419798 ↗
31. Hydrogel-based colorectal cancer organoid co-culture models10.1016/j.actbio.2020.12.037 ↗
32. Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachexia10.1002/jcsm.12627 ↗
33. Biofabrication of modular spheroids as tumor-scale microenvironments for drug screening10.1002/adhm.202201581 ↗
34. In vitro tissue-engineered adipose constructs for modeling disease10.1186/s42490-019-0027-7 ↗
35. Advances and challenges in organ-on-chip technology: toward mimicking human physiology and disease in vitro10.1007/s11517-024-03062-7 ↗
36. Active tissue stiffness modulation controls valve interstitial cell phenotype and osteogenic potential in 3D culture10.1016/j.actbio.2016.03.007 ↗
37. Effects of tunable, 3D-bioprinted hydrogels on human brown adipocyte behavior and metabolic function10.1016/j.actbio.2018.03.021 ↗
38. Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization10.1101/gad.263327.115 ↗
39. Mesenchymal plasticity regulated by Prrx1 drives aggressive pancreatic cancer biology10.1053/j.gastro.2020.09.010 ↗
40. Matrix stiffness of GelMA hydrogels regulates lymphatic endothelial cells toward enhanced lymphangiogenesis10.1021/acsami.4c11767 ↗
41. Tuning of mechanical properties in photopolymerizable gelatin-based hydrogels for in vitro cell culture systems10.1021/acsapm.2c01980 ↗
42. Hybrid methacrylated gelatin and hyaluronic acid hydrogel scaffolds. Preparation and systematic characterization for prospective tissue engineering applications10.3390/ijms22136758 ↗
43. Fat wasting is damaging: role of adipose tissue in cancer-associated cachexia10.3389/fcell.2020.00033 ↗
44. Cachexia and brown fat: aburning issue in cancer10.1016/j.trecan.2016.07.005 ↗
45. Expression of uncoupling proteins-1, −2 and −3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor10.1038/sj.bjc.6600101 ↗
46. PRRX1 is a master transcription factor of stromal fibroblasts for myofibroblastic lineage progression10.1038/s41467-022-30484-4 ↗
47. Tumor–stroma cross-talk in human pancreatic ductal adenocarcinoma: a focus on the effect of the extracellular matrix on tumor cell phenotype and invasive potential10.3390/cells7100158 ↗
48. Dynamic stromal alterations influence tumor-stroma crosstalk to promote pancreatic cancer and treatment resistance10.3390/cancers13143481 ↗
49. Metabolic reprogramming in adipose tissue during cancer cachexia10.3389/fonc.2022.848394 ↗
50. Abnormal lipid metabolism in cancer-associated cachexia and potential therapy strategy10.3389/fonc.2023.1123567 ↗
51. Cancer cachexia: malignant inflammation, tumorkines, and metabolic mayhem10.1016/j.tem.2012.10.006 ↗
52. Metabolic and histomorphological changes of adipose tissue in cachexia10.1097/MCO.0000000000000923 ↗